Wearable devices that monitor heart rate and other vital signs may interfere with pacemakers, ICDs, and cardiac resynchronization therapy devices, new research suggests.
A study challenges the dogma of beta-blockers for HF with preserved ejection fraction. For now, the strategy might only be for HFpEF patients already with pacemakers.
Most pacemaker pocket infections, without lead involvement, responded completely to antibiotics given locally at high concentrations in a case-control study.